Drawing for KEOPS

USPTO serial 98878257

KEOPS

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
HOFFMAN, CHRISTOPHER J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KEOPS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper

Maury M. Tepper Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
044Pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services; pharmacy consulting, namely, consulting in the field of preparing prescriptions in pharmaciesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jul 30, 2026MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Jul 30, 2026ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 29, 2026EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 1, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 5, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 5, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 25, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 24, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 24, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jun 24, 2025CNSLSUSPENSION LETTER WRITTEN—
Jun 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2025DOCKASSIGNED TO EXAMINER—
Apr 27, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 29, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 29, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance